Uncategorized

BIG news

Every so often we come across research that is so outstanding that we feel it’s our duty to share it with everyone. News that is so BIG that it should not go unnoticed. According to a study by the Department of Medicine at the Sir Ganga Ram Hospital (SGRH) in New Delhi and Moti Lal Nehru Medical College, Allahabad, people with BIGGER thighs were less likely to have diabetes. These findings...

Simple Math

This morning per a press release; “DarioHealth Corp. (DRIO), a leading global digital health company with mobile health and big data solutions, announced today the launch and first sales of its Dario™ Blood Glucose Monitoring System on Amazon.” Now just in case anyone has forgotten the Dario system is one of the many way cool whiz bang conventional glucose monitors. You know the ones we’re talking about those way cool whiz bang...

What lies ahead for Tandem?

Although we don’t often say it things have been going well for Tandem (NASDAQ: TNDM) these days. In Vienna at ATTD they had some amazing data, back at home they raised $60 million and they signed their first international distribution agreement. As Momma Kliff used to say not a bad few days. However even with this good news questions remain the biggest being where they go from here. Or as...

The Coming Debate

As we leave Vienna our thoughts turn to what does this all mean, what was the most significant takeaway. By far the most significant development coming out of ATTD is the long quest to have a REAL closed loop insulin delivery system is no longer a pipe dream. This is going to happen and for once we believe it will happen in our lifetime. It is difficult to overstate the...

ATTD Day Three – Lots of wackiness

Ok a word of advice as we would recommend sitting down while reading this post as we are going to say something positive about Tandem (NASDAQ: TNDM). However before we get to Tandem lets cover a few other items first. 1. As we noted you can’t swing a dead cat around here without hitting yet another “smart” insulin pen company. Now some of these companies have nothing more than a prototype...

ATTD Day Two- Smallest Piece of the pie

Here at the toy fair, oh excuse us, ATTD it dawned on us just how much of a disconnect there is between what’s happen in Vienna and whats happening in the real world. There is lots of excitement here about CGM and the promise of better closed loop technology coming down the pipe. So much so that tomorrow we’re going to get up early and do something we don’t much...

ATTD Day Two

Yes we realize that this is a diabetes technology conference, i.e. a toy show, but why is it as we walk around the exhibits and talk with everyone we feel sorry for that dead cat. You can’t swing that dead cat around here without hitting; “Smart” insulin pens Cloud enabled conventional blood glucose meters Continuous glucose monitoring systems Insulin pumps patch and conventional Now that cat might feel a little better IF – all of...

ATTD Day One

First and foremost a Happy Valentines Day to everyone especially to the Diabetic Investor wine consultant who unfortunately could not make here to Vienna. Now onto the business at hand a few quick observations; 1. As has become our standard operating procedure at events such as these we’ll write when we have time but given the time difference between Vienna and the US that might work out ok for all concerned. 2....

Knew this was coming

As we head to ATTD in Vienna comes news that FitBit has bought Twine Health. According to FitBit; “Fitbit is pleased to announce that we’re acquiring Twine Health, a clinically proven health coaching platform that allows people to take control of their health and achieve better outcomes. Twine’s user-friendly, engaging experience has enabled workplace health providers to deliver better coaching to people managing chronic conditions.” Remember FitBit has also invested $6 million...

A Head Scratcher

Ok we know its Friday and the weekends beckons before us, but we are having a dickens of a time figuring out just what’s going on with our friends in beautiful San Diego, Tandem (NASDAQ: TNDM). At this point everyone knows what the company is doing that is clear. What isn’t clear is why investors are buying the stock or what story is Oppenheimer, the lead underwriter, telling. Yesterday shares opened...